Gene expression profiling of peripheral blood cells for early detection of breast cancer

Breast Cancer Research

Volumn 12, Issue 1, 2010, Pages

  Aarøe, Jørgen ^a,f   Lindahl, Torbjørn ^b   Dumeaux, Vanessa ^c   Sæbø, Solve ^d   Tobin, Derek ^b   Hagen, Nina ^b   Skaane, Per ^e,f   Lönneborg, Anders ^b   Sharma, Praveen ^b   Børresen Dale, Anne Lise ^a,f  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b DiaGenic ASA   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

^d NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^e ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; FEMALE; GENE CONTROL; GENE EXPRESSION PROFILING; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; SENSITIVITY AND SPECIFICITY; STEROID METABOLISM; BLOOD CELL; BREAST TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHODOLOGY; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; BLOOD CELLS; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED;

EID: 77954083699     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2472     Document Type: Article

References (41)

1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006, 24:2137-2150. 10.1200/JCO.2005.05.2308, 16682732.
2. Cancer Registry of Norway. Cancer in Norway 2007 Cancer incidence, mortality, survival and prevalence in Norway. Bray, F 2008, Ref Type 2007: Report, Cancer Registry of Norway. Cancer in Norway 2007.
3. Chu KC, Tarone RE, Kessler LG, Ries LA, Hankey BF, Miller BA, Edwards BK. Recent trends in U.S. breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 1996, 88:1571-1579. 10.1093/jnci/88.21.1571, 8901855.
4. Weedon-Fekjaer H, Lindqvist BH, Vatten LJ, Aalen OO, Tretli S. Breast cancer tumor growth estimated through mammography screening data. Breast Cancer Res 2008, 10:R41. 10.1186/bcr2092, 2481488, 18466608.
5. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 2002, 225:165-175. 10.1148/radiol.2251011667, 12355001.
6. Achiron A, Gurevich M, Friedman N, Kaminski N, Mandel M. Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity. Ann Neurol 2004, 55:410-417. 10.1002/ana.20008, 14991819.
7. Gladkevich A, Kauffman HF, Korf J. Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:559-576. 10.1016/j.pnpbp.2004.01.009, 15093964.
8. Tang Y, Nee AC, Lu A, Ran R, Sharp FR. Blood genomic expression profile for neuronal injury. J Cereb Blood Flow Metab 2003, 23:310-319. 10.1097/00004647-200303000-00006, 12621306.
9. Twine NC, Stover JA, Marshall B, Dukart G, Hidalgo M, Stadler W, Logan T, Dutcher J, Hudes G, Dorner AJ, Slonim DK, Trepicchio WL, Burczynski ME. Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma. Cancer Res 2003, 63:6069-6075.
10. Han M, Liew CT, Zhang HW, Chao S, Zheng R, Yip KT, Song ZY, Li HM, Geng XP, Zhu LX, Lin JJ, Marshall KW, Liew CC. Novel blood-based, five-gene biomarker set for the detection of colorectal cancer. Clin Cancer Res 2008, 14:455-460. 10.1158/1078-0432.CCR-07-1801, 18203981.
11. Burczynski ME, Twine NC, Dukart G, Marshall B, Hidalgo M, Stadler WM, Logan T, Dutcher J, Hudes G, Trepicchio WL, Strahs A, Immermann F, Slonim DK, Dorner AJ. Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma. Clin Cancer Res 2005, 11:1181-1189.
12. Sharma P, Sahni NS, Tibshirani R, Skaane P, Urdal P, Berghagen H, Jensen M, Kristiansen L, Moen C, Sharma P, Zaka A, Arnes J, Sauer T, Akslen LA, Schlichting E, Borresen-Dale AL, Lonneborg A. Early detection of breast cancer based on gene-expression patterns in peripheral blood cells. Breast Cancer Res 2005, 7:R634-R644. 10.1186/bcr1203, 1242124, 16168108.
13. Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 2002, 99:6567-6572. 10.1073/pnas.082099299, 124443, 12011421.
14. R Development Core Team R A Language and Environment for Statistical Computing. 2009, Ref Type: Computer Program, R Development Core Team R.
15. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5:R80. 10.1186/gb-2004-5-10-r80, 545600, 15461798.
16. Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R, Botstein D, Altman RB. Missing value estimation methods for DNA microarrays. Bioinformatics 2001, 17:520-525. 10.1093/bioinformatics/17.6.520, 11395428.
17. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002, 30:207-210. 10.1093/nar/30.1.207, 99122, 11752295.
18. Nguyen DV, Rocke DM. Partial least squares proportional hazard regression for application to DNA microarray survival data. Bioinformatics 2002, 18:1625-1632. 10.1093/bioinformatics/18.12.1625, 12490447.
19. Wold H. Estimation of principal components and related models by iterative least squares. Multivariate Analysis 1966, 391-420. New York: Academic Press, Krishnaiah PR.
20. Gidskehaug L, Anderssen E, Flatberg A, Alsberg BK. A framework for significance analysis of gene expression data using dimension reduction methods. BMC Bioinformatics 2007, 8:346. 10.1186/1471-2105-8-346, 2194745, 17877799.
21. Wu CFJ. Jackknife, bootstrap and other resampling plans in regression analysis. The Annals of Statistics 1986, 14:1261-1350.
22. Varma S, Simon R. Bias in error estimation when using cross-validation for model selection. BMC Bioinformatics 2006, 7:91. 10.1186/1471-2105-7-91, 1397873, 16504092.
23. Goeman JJ, Geer SA, de Kort F, van Houwelingen HC. A global test for groups of genes: testing association with a clinical outcome. Bioinformatics 2004, 20:93-99. 10.1093/bioinformatics/btg382, 14693814.
24. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol 2003, 4:P3. 10.1186/gb-2003-4-5-p3, 12734009.
25. Huttenhower C, Haley EM, Hibbs MA, Dumeaux V, Barrett DR, Coller HA, Troyanskaya OG. Exploring the human genome with functional maps. Genome Res 2009, 19:1093-1106. 10.1101/gr.082214.108, 2694471, 19246570.
26. Graphle. 2009, Ref Type: Computer Program., http://sonorus.princeton.edu/graphle/
27. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002, 3:991-998. 10.1038/ni1102-991, 12407406.
28. Jain A, Patil VP, Fung J. Incidence of de novo cancer and lymphoproliferative disorders after liver transplantation in relation to age and duration of follow-up. Liver Transpl 2008, 14:1406-1411. 10.1002/lt.21609, 18825680.
29. Koga Y, Matsuzaki A, Suminoe A, Hattori H, Hara T. Neutrophil-derived TNF-related apoptosis-inducing ligand (TRAIL): a novel mechanism of antitumor effect by neutrophils. Cancer Res 2004, 64:1037-1043. 10.1158/0008-5472.CAN-03-1808, 14871835.
30. Cho H, Hur HW, Kim SW, Kim SH, Kim JH, Kim YT, Lee K. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother 2008, 58:15-23. 10.1007/s00262-008-0516-3, 18414853.
31. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005, 91:181-184. 10.1002/jso.20329, 16118772.
32. De Larco JE, Wuertz BR, Furcht LT. The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clin Cancer Res 2004, 10:4895-4900. 10.1158/1078-0432.CCR-03-0760, 15297389.
33. Bezault J, Bhimani R, Wiprovnick J, Furmanski P. Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res 1994, 54:2310-2312.
34. Rodrigues L, Teixeira J, Schmitt F, Paulsson M, Mansson HL. Lactoferrin and cancer disease prevention. Crit Rev Food Sci Nutr 2009, 49:203-217. 10.1080/10408390701856157, 19093266.
35. Kuopio T, Kankaanranta A, Jalava P, Kronqvist P, Kotkansalo T, Weber E, Collan Y. Cysteine proteinase inhibitor cystatin A in breast cancer. Cancer Res 1998, 58:432-436.
36. Levicar N, Kos J, Blejec A, Golouh R, Vrhovec I, Frkovic-Grazio S, Lah TT. Comparison of potential biological markers cathepsin B, cathepsin L, stefin A and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients. Cancer Detect Prev 2002, 26:42-49. 10.1016/S0361-090X(02)00015-6, 12088202.
37. Yang J, Bielenberg DR, Rodig SJ, Doiron R, Clifton MC, Kung AL, Strong RK, Zurakowski D, Moses MA. Lipocalin 2 promotes breast cancer progression. Proc Natl Acad Sci USA 2009, 106:3913-3918. 10.1073/pnas.0810617106, 2656179, 19237579.
38. Tisdale MJ. Cachexia in cancer patients. Nat Rev Cancer 2002, 2:862-871. 10.1038/nrc927, 12415256.
39. Gercel-Taylor C, Doering DL, Kraemer FB, Taylor DD. Aberrations in normal systemic lipid metabolism in ovarian cancer patients. Gynecol Oncol 1996, 60:35-41. 10.1006/gyno.1996.0008, 8557225.
40. McAndrew PF. Fat metabolism and cancer. Surg Clin North Am 1986, 66:1003-1012.
41. Mackay J, Burford A, Sajun S, Pithers A. Clinical implications of gene expression profiling in cancer. Asia Pacific J of Oncology and Hematology 2009, 1:13-17.